Eli Lilly posts strong Phase 3 win for Jaypirca combo in blood cancer trial
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
The event also featured discussions on emerging trends in joint replacement surgery
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
The trial also demonstrated significant improvements across multiple secondary endpoints
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Subscribe To Our Newsletter & Stay Updated